'who gmp certified pharmaceutical products'

Chemsroot Pharmaceutical LLP presents LETKUF-PDC, an effective Pediatric Cough Syrup formulated with a balanced blend of safe and reliable ingredients. Specially designed for children, it provides quick relief from cough, throat irritation, nasal congestion, and respiratory discomfort. Its gentle yet powerful composition ensures effective symptom control without drowsiness. Manufactured under WHO-GMP certified standards, LETKUF-PDC is trusted by doctors for fast, safe, and child-friendly respiratory care.

Chemsroot Pharmaceutical LLP introduces MEFLET-P, a powerful combination of Mefenamic Acid and Paracetamol. Specially designed to relieve pain, fever, inflammation, and discomfort caused by musculoskeletal conditions, dysmenorrhea, dental pain, and post-surgical pain. Its dual-action formula ensures quick relief and long-lasting effectiveness, enhancing patient recovery and comfort. Manufactured under WHO-GMP certified standards, MEFLET-P delivers trusted safety, efficacy, and consistent quality for reliable healthcare outcomes.

Chemsroot Pharmaceutical LLP presents MONTICHEM-LC, a trusted combination of Montelukast and Levocetirizine. Specially formulated to provide effective relief from allergic rhinitis, seasonal allergies, sneezing, runny nose, and asthma-related symptoms, it works by reducing inflammation and controlling allergic responses. MONTICHEM-LC ensures long-lasting relief, improving patient comfort and quality of life. Manufactured under WHO-GMP certified facilities, it guarantees high standards of safety, efficacy, and reliability.

Chemsroot Pharmaceutical LLP introduces PALMIROOT-LC, a trusted formulation combining Levocetirizine and Montelukast for effective relief from respiratory and allergic conditions. It is widely prescribed for allergic rhinitis, asthma, seasonal allergies, and chronic urticaria. By reducing inflammation and blocking histamine receptors, PALMIROOT-LC provides fast, long-lasting comfort. Produced under WHO-GMP certified standards, it ensures safety, efficacy, and reliability, making it a preferred choice for comprehensive allergy and respiratory care.

Chemsroot Pharmaceutical LLP presents PANTOIC-DSR, a highly effective dual-release formulation combining Pantoprazole and Domperidone. It is specially designed to manage gastroesophageal reflux disease (GERD), acidity, heartburn, gastritis, and dyspepsia. With its sustained action, PANTOIC-DSR not only reduces excess stomach acid but also improves gastric motility, offering long-lasting relief. Manufactured under WHO-GMP certified standards, it ensures safety, efficacy, and reliable therapeutic outcomes for better patient care.

Chemsroot Pharmaceutical LLP introduces SUCROT, a reliable and effective formulation crafted to support gastric health and relieve acid-related disorders. Designed with high-quality ingredients, SUCROT offers fast relief from acidity, heartburn, and indigestion, while protecting the stomach lining. Manufactured under WHO-GMP certified standards, it ensures safety, purity, and long-lasting efficacy. SUCROT is trusted by healthcare professionals for superior patient outcomes in managing gastric discomfort.

Chemsroot Pharmaceutical LLP introduces MOXROOT-625 LB, a potent blend of Amoxicillin, Clavulanic Acid, and Lactobacillus. This advanced antibiotic formulation not only combats a wide range of bacterial infections but also helps restore and maintain gut health by preventing antibiotic-associated imbalances. Ideal for respiratory, urinary, skin, soft tissue, and ENT infections, MOXROOT-625 LB is manufactured under strict WHO-GMP standards, ensuring safety, efficacy, and patient well-being.

Chemsroot Pharmaceutical LLP presents MOXROOT-625, a powerful combination of Amoxicillin and Clavulanic Acid formulated to combat a wide range of bacterial infections. Widely prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and ENT infections, MOXROOT-625 offers enhanced antibacterial activity and rapid relief. Manufactured under stringent WHO-GMP guidelines, it ensures high efficacy, safety, and reliability, making it a trusted solution for effective infection management.

Chemsroot Pharmaceutical LLP introduces PLACEF-O, a powerful combination antibiotic designed to effectively treat a wide range of bacterial infections. With its dual-action formulation, it offers enhanced efficacy in managing respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue conditions, and gastrointestinal infections. Manufactured under WHO-GMP standards, PLACEF-O ensures high quality, safety, and reliable therapeutic outcomes, making it a trusted solution for healthcare professionals.